Limited Access Protocol for the Use of Oral Cisapride

Limited Access, Open-label, Compassionate Use of Cisapride in the Treatment of Gastroparesis

Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the compassionate use of cisapride to treat patients who had no other effective therapy. For this observational study, 3 patients who had already been prescribed cisapride by outside physicians, were followed to determine the effectiveness of cisapride on their gastric emtpying.

Inclusion Criteria:

• Clinical diagnosis of gastroparesis.

Exclusion Criteria:

• No diagnosis of gastroparesis.